MAXHEALTH Stock Overview
Provides medical and healthcare services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for MAXHEALTH from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Max Healthcare Institute Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,141.10 |
| 52 Week High | ₹1,215.55 |
| 52 Week Low | ₹651.40 |
| Beta | 0.30 |
| 1 Month Change | 14.12% |
| 3 Month Change | 10.74% |
| 1 Year Change | 75.85% |
| 3 Year Change | 168.43% |
| 5 Year Change | n/a |
| Change since IPO | 1,567.06% |
Recent News & Updates
We Think Max Healthcare Institute (NSE:MAXHEALTH) Can Stay On Top Of Its Debt
Nov 30
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Nov 09Recent updates
We Think Max Healthcare Institute (NSE:MAXHEALTH) Can Stay On Top Of Its Debt
Nov 30Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Nov 09Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now
Sep 14Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Jul 18Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark
Jun 21Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Shareholder Returns
| MAXHEALTH | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -3.7% | -1.3% | -4.3% |
| 1Y | 75.9% | 41.8% | 19.1% |
Return vs Industry: MAXHEALTH exceeded the Indian Healthcare industry which returned 41.8% over the past year.
Return vs Market: MAXHEALTH exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility
| MAXHEALTH volatility | |
|---|---|
| MAXHEALTH Average Weekly Movement | 4.7% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: MAXHEALTH has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: MAXHEALTH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 19,500 | Abhay Soi | www.maxhealthcare.in |
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management.
Max Healthcare Institute Limited Fundamentals Summary
| MAXHEALTH fundamental statistics | |
|---|---|
| Market cap | ₹1.11t |
| Earnings (TTM) | ₹10.59b |
| Revenue (TTM) | ₹60.08b |
104.7x
P/E Ratio18.5x
P/S RatioIs MAXHEALTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MAXHEALTH income statement (TTM) | |
|---|---|
| Revenue | ₹60.08b |
| Cost of Revenue | ₹22.65b |
| Gross Profit | ₹37.43b |
| Other Expenses | ₹26.84b |
| Earnings | ₹10.59b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 10.89 |
| Gross Margin | 62.30% |
| Net Profit Margin | 17.63% |
| Debt/Equity Ratio | 13.5% |
How did MAXHEALTH perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield14%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 22:57 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Max Healthcare Institute Limited is covered by 29 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Bhasin | Ambit Capital |
| Prashant Nair | Ambit Capital |
| null null | Anand Rathi Shares and Stock Brokers Limited |